| EVOLUS INC. DL-,00001 |
| USA |
| Gesundheit |
| US30052C1071 / A2JDYX |
| EVL (Frankfurt) / EOLS (NASDAQ) |
| FRA:EVL, ETR:EVL, EVL:GR, NASDAQ:EOLS |
| - |
| https://www.evolus.com/ |
|
Evolus is a performance beauty company specializing in injectable aesthetic products within the global cash-pay aesthetics market across the United States, Canada, Europe, and Australia. The company's flagship product, Jeuveau, is a proprietary botul..
>Volltext.. |
| 295.87 Mio. EUR |
| 382.08 Mio. EUR |
| 253.55 Mio. EUR |
| -24.62 Mio. EUR |
| -44.06 Mio. EUR |
| -0.69 EUR |
| 132.24 Mio. EUR |
| 45.92 Mio. EUR |
| -36.06 Mio. EUR |
| 0.71 |
| -1.63% |
| 9.72% |
| - |
| - |
| - |
| - |
| EVOLUS |
| 05.05.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|